Medicure (MCUJF) Cash from Investing Activities (QoQ) (2010 - 2026)
Medicure (MCUJF) Cash from Investing Activities (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Medicure | 8.77 Mn | 7.64 Mn | 2.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -387.75% |
| Jun 30, 2025 | -212.39% |
| Mar 31, 2025 | -17.78% |
| Dec 31, 2024 | -337.49% |
| Sep 30, 2024 | 3.59% |
| Jun 30, 2024 | -17.77% |
| Mar 31, 2024 | 31.33% |
| Dec 31, 2023 | -9.60% |
| Sep 30, 2022 | -64.35% |
| Jun 30, 2022 | -238.21% |
| Sep 30, 2017 | 68.95% |
| Jun 30, 2017 | -167.67% |
| Mar 31, 2017 | 96.90% |
| Dec 31, 2016 | -153,833.43% |
| Sep 30, 2016 | 23.92% |
| Jun 30, 2016 | 27.88% |
| Mar 31, 2016 | -116.78% |
| Dec 31, 2015 | 510.47% |
| Sep 30, 2015 | -230.79% |
| Jun 30, 2015 | 35.54% |